Theragenics (TGX) on the up and up Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Theragenics (TGX) on the up and up

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ron Kline who wrote (918)	7/2/1998 7:25:00 PM
From: BDR	Read Replies (1) of 1055

RESEARCH ALERT - Dain cuts brachytherapy cos NEW YORK, July 2 (Reuters) - Dain Rauscher Wessels said Thursday it has lowered its rating on three brachytheraphy or cancer treatment providers. -- Theragenics Corp. (THRX - news) cut to neutral from a buy-aggressive. -- Mentor Corp. (MNTR - news) cut to neutral from buy. -- North American Scientific Inc. (NASI - news) cut to neutral from strong buy. -- Analyst Parice Halbert said supply in sector will overtake demand sooner than expected due to rival Anglo-Norwegian health technology company Nycomed Amersham (NYE - news) escalating its capacity expansion sooner than anticipated. -- ******In addition, an article in June 1998 edition of Urology, comes out in favor of radical prostatectomy over using Iodine seeds on the basis of seven-year disease free rates.**** -- Halbert lowers Theragenics' fiscal 1999 earnings per share estimate to $0.67 from $0.77. Also cuts fiscal 2000 EPS to $0.99 from $1.21. Leaves fiscal 1998 EPS unchanged at $0.45. -- Halbert lowers 1999 EPS estimate for North American Scientific to $0.68 from $0.79, and fiscal 2000 cut to $0.89 from $1.16. -- Halbert also lowers Mentor's 1999 and 2000 EPS. -- Halbert said seed prices expected to fall 20 percent in 1999 from current levels, and 30 percent from current levels in 2000 due to growing potential for excess capacity. -- U.S. companies will have to ''compete head-to-head sooner than expected to hold or grow market share from Amersham or any new entrants'', Halbert said. -- Theragenics off 7-3/16 at 15-1/16. North American Scientific off 3-3/4 at 15-1/4. Mentor sheds 2-3/16 to 21-15/16. Nycomed Amersham up 7/8 at 37.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next